This website is intended for healthcare professionals


Prescribing in cancer care

This article, published in the Journal of Advanced Nursing, sought to review the evidence surrounding nurse and pharmacist review of patients undergoing systemic anti-cancer therapy (SACT).

Maintenance niraparib therapy for patients with relapsed platinum sensitive ovarian cancer: experience at a south coast network

PARP inhibitors have recently entered the treatment pathway for gynaecological cancers; primarily ovarian, fallopian tube and peritoneal cancers (The National Institute of Health and Care Excellence...

Drug Updates: September

Following new draft guidance from the National Institute for Health and Care Excellence (NICE), midostaurin (Rydapt, Novartis) has been recommended for the treatment of advanced systemic mastocytosis...

Nutrition and oncology: best practice and the development of a traffic light system

Multidisciplinary working is vital to proactively manage the nutritional care of oncology patients, whether this is via oral nutritional support or prophylactic/reactive enteral feeding..

Medicines reconciliation of biologics on a primary care clinical system

DMARDs (Disease Modifying Anti-Rheumatic Drugs) such as methotrexate, azathioprine and leflunomide, licensed in dermatological, gastrointestinal and rheumatic conditions are not strictly biologics....

Prescribing practices for tumour aggressiveness and castration resistance in risk-stratified prostate cancer patients

This cross-sectional study lasted one year and was conducted in accordance with the Declaration of Helsinki regarding human experiments. The institutional ethics committee approved this study...

Cardiac effects of cancer therapy and what is being done about it

The drug doxorubicin slows or stops the spread of cancer cells by blocking the enzyme, topoisomerase, which cancer cells rely on for their division and growth (Cancer Research UK (CRUK), 2019). It is...

Reframing the way we think about cancer therapy

One such therapy, first offered to patients in the UK in early 2019, is chimeric antigen receptor T-cell (CAR-T). CAR-T forms part of a newer class of medicines called advanced therapy medicinal...

Prescribing for persistent cancer pain: focus on chemotherapy-induced peripheral neuropathy

The use of systemic chemotherapy as a treatment modality for cancer is widely used, with around one-third of all individuals receiving chemotherapy as part of their treatment (National Cancer...

Managing pain in oncology

The two broad categories of pain are nociceptive and neuropathic. Results of laboratory tests, imaging studies, history, and physical findings play an important role in determining pain...

Why choose Journal of Prescribing Practice?

Journal of Prescribing Practice shares the latest clinical expertise and professional guidance for non-medical prescribers. Our goal is to provide the knowledge to help you prescribe more efficiently and effectively.

What's included

  • Evidence-based best practice

  • Drug updates

  • Pharmacology information

  • Calculation skills

Subscriptions start:

From £16.25 GBP